完整後設資料紀錄
DC 欄位語言
dc.contributor.authorTsou, Yung Anen_US
dc.contributor.authorHuang, Hung-Jinen_US
dc.contributor.authorLin, Wesley Wen Yangen_US
dc.contributor.authorChen, Calvin Yu-Chianen_US
dc.date.accessioned2014-12-08T15:36:10Z-
dc.date.available2014-12-08T15:36:10Z-
dc.date.issued2014en_US
dc.identifier.issn1741-427Xen_US
dc.identifier.urihttp://hdl.handle.net/11536/24527-
dc.identifier.urihttp://dx.doi.org/10.1155/2014/907028en_US
dc.description.abstractThe innate immune system is the first line in the defense system and prevents the body from further bacteria, virus, or fungal infections. Most of the innate immune system is relevant tomucosa immunity. Lactotransferrin is secreted from the human mammal breast duct epithelial tissue and strengthens infant immunity to defense with regard to outward pathogens. Splunc-1 is also an innate material secreted from the soft palate, lung, nasal cavity epithelium, and mucosa. It helps with mucosa defense against bacterial, virus, and even fungus. LPS is the main etiology of Gram-negative bacilla infection source. And studies of lactoferricin and slpunc1 both can combine with LPS and subsequently cause insults to the mucosa. Although, we know that both of them partake in an important role in innate immunity, we do not know the effects when they work together. In this study, we just overview silicon stimulation to examine the combination of Lactoferricin and Splunc-1 and the effect with regard to LPS.en_US
dc.language.isoen_USen_US
dc.titleInvestigation of Anti-Infection Mechanism of Lactoferricin and Splunc-1en_US
dc.typeArticleen_US
dc.identifier.doi10.1155/2014/907028en_US
dc.identifier.journalEVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINEen_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.identifier.wosnumberWOS:000335729600001-
dc.citation.woscount0-
顯示於類別:期刊論文


文件中的檔案:

  1. 000335729600001.pdf

若為 zip 檔案,請下載檔案解壓縮後,用瀏覽器開啟資料夾中的 index.html 瀏覽全文。